Foundation Medicine Inc Stock

Stocks

21/10/18	Bayer : Roche takes on Loxo, Bayer in gene-defined cancer class	RE
19/06/18	Citigroup : Roche pays $2.4 billion for rest of cancer expert Foundation Medicine	RE
04/12/17	Foundation Medicine : Roche's Foundation Medicine wins FDA blessing for new cancer test	RE
13/01/15	Alcoa : Wall St. falls; energy shares dragged down further by oil	RE
12/01/15	Foundation Medicine : Roche in $1 billion-plus Foundation Medicine deal to boost cancer efforts	RE

07/08/18	Foundation Medicine : Setting the Pace for Blood Tumor Mutational Burden	PU
06/08/18	Foundation Medicine : Publishes New Data in Nature Medicine Supporting Blood Tumor Mutational Burden (bTMB) as a Novel Predictor of Response to Cancer Immunotherapy	BU
19/07/18	Foundation Medicine : and Guardant Health Agree to Settle Patent Infringement Lawsuit	BU
03/07/18	Beyond MSI: Expanding the Reach of Immunotherapy in Colorectal Cancer	PU
20/06/18	FOUNDATION MEDICINE, INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout	BU

19/06/18	Les valeurs à suivre aujourd'hui à Wall Street Mardi 19 juin 2018
19/06/18	Dow Jones Industrial Average : Les valeurs à suivre à Wall Street
19/06/18	FOUNDATION MEDICINE : racheté par ROCHE
19/06/18	USA-Les valeurs à suivre à Wall Street (actualisé)
19/06/18	Foundation Medicine : Roche will US-Gentest-Firma FMI ganz schlucken

Manager	Title	Age	Since
Daniel Malarek CEO	Chief Executive Officer	-	01/11/2023
Dominique Schutz DFI	Director of Finance/CFO	-	01/01/2022
Michael Kling CTO	Chief Tech/Sci/R&D Officer	-	-

Director	Title	Age	Since
Evan Jones BRD	Director/Board Member	69	08/01/2013

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
FOUNDATION MEDICINE INC	-.--%	-.--%	-	-	0
LONZA GROUP AG	-1.01%	+1.48%	+1.66%	+23.62%	51.65B
REVOLUTION MEDICINES, INC.	+1.15%	+0.58%	+479.20%	+569.23%	45.31B
IQVIA HOLDINGS INC.	+0.85%	+4.99%	+39.39%	+18.00%	42.7B
BEONE MEDICINES AG	-0.30%	-0.30%	+21.64%	+85.93%	42.79B
CELLTRION, INC.	-2.27%	-3.02%	+14.22%	+51.50%	32.87B
MEDPACE HOLDINGS, INC.	+0.88%	+1.76%	+31.90%	+136.57%	17.14B
ASCENDIS PHARMA A/S	-0.89%	-3.16%	-	-	16.61B
EUROFINS SCIENTIFIC SE	-1.70%	+3.06%	+11.11%	+28.57%	15.01B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-0.14%	+2.36%	+81.32%	+49.35%	14.21B
Average	-0.30%	+2.97%	+85.05%	+120.35%	30.92B
Weighted average by Cap.	-0.22%	+2.74%	+102.19%	+139.94%